FDA pulls common heartburn drug from US market after carcinogen concerns
After a year of investigation the US Food and Drug Administration (FDA) has completely withdrawn all ranitidine products from the American market. Studies have revealed levels of a carcinogenic compound can increase in the product over time, particular… Continue reading FDA pulls common heartburn drug from US market after carcinogen concerns